|
Momodou
Denmark
11639 Posts |
 Posted - 08 Oct 2013 : 09:06:49
|
UK firm to seek approval for malaria vaccine
08 Oct 2013
Drug maker GSK to seek regulatory approval for prototype vaccine after trials show it offers partial shield for infants.
British drug maker GlaxoSmithKline (GSK) said it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease.
Results for the Phase III stage of the closely-followed RTS,S vaccine were unveiled on Tuesday at a conference in Durban, South Africa, gathering experts on malaria in Africa.
It showed that 18 months after vaccination, children aged five to 17 months had a 46-percent reduction in the risk of clinical malaria compared to unvaccinated peers.
But in infants aged six to 12 weeks at the time of vaccination, efficacy was lower: a 27-percent reduction in risk.
A spokeswoman for GSK told AFP news agency that the company would file an application to the European Medicines Agency (EMA) under a process aimed at facilitating new drugs for poorer countries......
Read Full Story
Related: UK firm seeks to market world's first malaria vaccine
|
A clear conscience fears no accusation - proverb from Sierra Leone |
|
Topic Locked
